Small ruminant lentiviruses and human immunodeficiency virus: Cousins that take a long view

Current HIV Research

Volumn 8, Issue 1, 2010, Pages 26-52

  Blacklaws, Barbara A ^a   Harkiss, Gordon D ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Lentiviruses; Pathogenesis; Pathology

Indexed keywords

GAG PROTEIN; NEF PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIF PROTEIN; VPR PROTEIN;

ADAPTIVE IMMUNITY; ARTHROPATHY; B LYMPHOCYTE ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATION; ENVELOPE GENE; GENE STRUCTURE; GOAT; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; INNATE IMMUNITY; LAMB; LENTIVIRINAE; LUNG DISEASE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MASTITIS; MONOCYTE; NONHUMAN; PATHOGENESIS; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; SHEEP; SMALL RUMINANT LENTIVIRUS; STRUCTURAL GENE; T LYMPHOCYTE ACTIVATION; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; DENDRITIC CELLS; DISEASE PROGRESSION; GENOME, VIRAL; HIV; HUMANS; IMMUNITY, CELLULAR; LENTIVIRUS; LENTIVIRUS INFECTIONS; MACROPHAGES; VIRAL TROPISM; VIRUS LATENCY;

EID: 77949704913     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016210790416406     Document Type: Review

References (428)

1. Sigurdsson B, Palsson PA. Visna of sheep; a slow, demyelinating infection. Br J Exp Pathol 1958; 39: 519-28.
2. Palsson PA. Maedi and visna in sheep. Front Biol 1976; 44: 17-43.
3. Crawford TB, Adams DS, Cheevers WP, Cork LC. Chronic arthritis in goats caused by a retrovirus. Science 1980; 207: 997-9.
4. Ellis TM, Robinson WF, Wilcox GE. The pathology and aetiology of lung lesions in goats infected with caprine arthritis-encephalitis virus. Aust Vet J 1988; 65: 69-73.
5. Narayan O, Clements JE. Biology and pathogenesis of lentiviruses. J Gen Virol 1989; 70(Pt 7): 1617-39.
6. Petursson G, Andresdottir V, Andresson O, et al. Human and ovine lentiviral infections compared. Comp Immunol Microbiol Infect Dis 1991; 14: 277-87.
7. Thormar H. Maedi-visna virus and its relationship to human immunodeficiency virus. AIDS Rev 2005; 7: 233-45.
8. Gendelman HE, Narayan O, Kennedy-Stoskopf S, et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986; 58: 67-74.
9. Narayan O, Kennedy-Stoskopf S, Sheffer D, Griffin DE, Clements JE. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 1983; 41: 67-73.
10. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 1985; 82: 7086-90.
11. Grossi P, Giudice C, Bertoletti I, et al. Immunohistochemical detection of the p27 capsid protein of caprine arthritis-encephalitis virus (CAEV) in bone-marrow cells of seropositive goats. J Comp Pathol 2005; 133: 197-200.
12. Ravazzolo AP, Nenci C, Vogt HR, et al. Viral load, organ distribution, histopathological lesions, and cytokine mRNA expression in goats infected with a molecular clone of the caprine arthritis encephalitis virus. Virology 2006; 350: 116-27.
13. Preziuso S, Renzoni G, Allen TE, et al. Colostral transmission of maedi visna virus: sites of viral entry in lambs born from experimentally infected ewes. Vet Microbiol 2004; 104: 157-64.
14. Carrozza ML, Mazzei M, Bandecchi P, Arispici M, Tolari F. In situ PCR-associated immunohistochemistry identifies cell types harbouring the Maedi-Visna virus genome in tissue sections of sheep infected naturally. J Virol Methods 2003; 107: 121-7.
15. Staskus KA, Couch L, Bitterman P, et al. In situ amplification of visna virus DNA in tissue sections reveals a reservoir of latently infected cells. Microb Pathog 1991; 11: 67-76.
16. Stowring L, Haase AT, Petursson G, et al. Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology 1985; 141: 311-8.
17. Hughes GJ, Cochrane A, Leen C, et al. HIV-1-infected CD8+CD4+ T cells decay in vivo at a similar rate to infected CD4 T cells during HAART. AIDS 2008; 22: 57-65.
18. Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009; 6: 51.
19. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004; 45: 549-59.
20. Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003; 9: 727-8.
21. Nottet HS, van Dijk SJ, Fanoy EB, et al. HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 50: 345-53.
22. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986; 68: 281-4.
23. Cambi A, Beeren I, Joosten B, Fransen JA, Figdor CG. The C-type lectin DC-SIGN internalizes soluble antigens and HIV-1 virions via a clathrin-dependent mechanism. Eur J Immunol 2009; 39: 1923-8.
24. Lyall JW, Solanky N, Tiley LS. Restricted species tropism of maedi-visna virus strain EV-1 is not due to limited receptor distribution. J Gen Virol 2000; 81: 2919-27.
25. Hotzel I, Cheevers WP. A maedi-visna virus strain K1514 receptor gene is located in sheep chromosome 3p and the syntenic region of human chromosome 2. J Gen Virol 2002; 83: 1759-64.
26. Hotzel I, Cheevers W. Differential receptor usage of small ruminant lentiviruses in ovine and caprine cells: host range but not cytopathic phenotype is determined by receptor usage. Virology 2002; 301: 21-31.
27. Jolly PE, Narayan O. Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses. J Virol 1989; 63: 4682-8.
28. Hotzel I, Cheevers WP. Host range of small-ruminant lentivirus cytopathic variants determined with a selectable caprine arthritis-encephalitis virus pseudotype system. J Virol 2001; 75: 7384-91.
29. Mselli-Lakhal L, Favier C, Leung K, et al. Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J Virol 2000; 74: 8343-8.
30. Chebloune Y, Sheffer D, Karr BM, Stephens E, Narayan O. Restrictive type of replication of ovine/caprine lentiviruses in ovine fibroblast cell cultures. Virology 1996; 222: 21-30.
31. Barnard RJ, Young JA. Alpharetrovirus envelope-receptor interactions. Curr Top Microbiol Immunol 2003; 281: 107-36.
32. Kennedy-Stoskopf S, Narayan O. Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol 1986; 59: 37-44.
33. Jolly PE, Huso D, Hart G, Narayan O. Modulation of lentivirus replication by antibodies. Non-neutralizing antibodies to caprine arthritis-encephalitis virus enhance early stages of infection in macrophages, but do not cause increased production of virions. J Gen Virol 1989; 70(Pt 8): 2221-6.
34. Jolly PE, Huso DL, Sheffer D, Narayan O. Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding, internalization, and neutralization of visna virus in macrophages. J Virol 1989; 63: 1811-3.
35. Willey S, Aasa-Chapman MM. Humoral immunity to HIV-1: neutralisation and antibody effector functions. Trends Microbiol 2008; 16: 596-604.
36. Peluso R, Haase A, Stowring L, Edwards M, Ventura P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985; 147: 231-6.
37. Haase AT. Pathogenesis of lentivirus infections. Nature 1986; 322: 130-6.
38. Small JA, Bieberich C, Ghotbi Z, et al. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol 1989; 63: 1891-6.
39. Clements JE, Payne SL. Molecular basis of the pathobiology of lentiviruses. Virus Res 1994; 32: 97-109.
40. Clements JE, Zink MC. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 1996; 9: 100-17.
41. Barber SA, Bruett L, Douglass BR, et al. Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol 2002; 76: 817-28.
42. th ed. Philadelphia: Lippincott, Williams & Wilkins. 2007; vol. 2.
43. Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000; 28: 663-8.
44. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest 2001; 107: 143-51.
45. Roulston A, Lin R, Beauparlant P, Wainberg MA, Hiscott J. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors. Microbiol Rev 1995; 59: 481-505.
46. Hoshino Y, Nakata K, Hoshino S, et al. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002; 195: 495-505.
47. Hess JL, Small JA, Clements JE. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: involvement of AP-1 sites in basal activity and trans-activation. J Virol 1989; 63: 3001-15.
48. Sutton KA, Lin CT, Harkiss GD, McConnell I, Sargan DR. Regulation of the long terminal repeat in visna virus by a transcription factor related to the AML/PEBP2/CBF superfamily. Virology 1997; 229: 240-50.
49. Campbell BJ, Avery RJ. Sequence analysis and transcriptional activity of the LTR of OLV-CU1, a North American ovine lentivirus. J Gen Virol 1996; 77(Pt 12): 2999-3004.
50. Barros SC, Andresdottir V, Fevereiro M. Cellular specificity and replication rate of Maedi Visna virus in vitro can be controlled by LTR sequences. Arch Virol 2005; 150: 201-13.
51. Gdovin SL, Clements JE. Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology 1992; 188: 438-50.
52. Sargan DR, Sutton KA, Bennet ID, McConnell I, Harkiss GD. Sequence and repeat structure variants in the long terminal repeat of maedi-visna virus EV1. Virology 1995; 208: 343-8.
53. Barros SC, Ramos F, Duarte M, et al. Genomic characterization of a slow/low maedi visna virus. Virus Genes 2004; 29: 199-210.
54. Brodie SJ, Marcom KA, Pearson LD, et al. Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia. J Infect Dis 1992; 166: 531-41.
55. Zhang Z, Watt NJ, Hopkins J, Harkiss G, Woodall CJ. Quantitative analysis of maedi-visna virus DNA load in peripheral blood monocytes and alveolar macrophages. J Virol Methods 2000; 86: 13-20.
56. Lairmore MD, Akita GY, Russell HI, DeMartini JC. Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol 1987; 61: 4038-42.
57. Herrmann-Hoesing LM, Noh SM, White SN, et al. Peripheral ovine progressive pneumonia provirus levels correlate with and predict histological tissue lesion severity in naturally infected sheep. Clin Vaccine Immunol 2009; 16: 551-7.
58. Agnarsdottir G, Thorsteinsdottir H, Oskarsson T, et al. The long terminal repeat is a determinant of cell tropism of maedi-visna virus. J Gen Virol 2000; 81: 1901-5.
59. Andresdottir V, Tang X, Agnarsdottir G, et al. Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus. Virus Genes 1998; 16: 281-93.
60. Oskarsson T, Hreggvidsdottir HS, Agnarsdottir G, et al. Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence. J Virol 2007; 81: 4052-7.
61. Tong-Starksen SE, Sepp T, Pagtakhan AS. Activation of caprine arthritis-encephalitis virus long terminal repeat by gamma interferon. J Virol 1996; 70: 595-9.
62. Murphy BG, Hotzel I, Jasmer DP, Davis WC, Knowles D. TNFalpha and GM-CSF-induced activation of the CAEV promoter is independent of AP-1. Virology 2006; 352: 188-99.
63. Ellis JA, Russell HI, Du CW. Effect of selected cytokines on the replication of Corynebacterium pseudotuberculosis and ovine lentiviruses in pulmonary macrophages. Vet Immunol Immunopathol 1994; 40: 31-47.
64. Zhang Z, Harkiss GD, Hopkins J, Woodall CJ. Granulocyte macrophage colony stimulating factor is elevated in alveolar macrophages from sheep naturally infected with maedi-visna virus and stimulates maedi-visna virus replication in macrophages in vitro. Clin Exp Immunol 2002; 129: 240-6.
65. Hess JL, Pyper JM, Clements JE. Nucleotide sequence and transcriptional activity of the caprine arthritis-encephalitis virus long terminal repeat. J Virol 1986; 60: 385-93.
66. Craig LE, Sheffer D, Meyer AL, et al. Pathogenesis of ovine lentiviral encephalitis: derivation of a neurovirulent strain by in vivo passage. J Neurovirol 1997; 3: 417-27.
67. Angelopoulou K, Poutahidis T, Brellou GD, Greenland T, Vlemmas I. A deletion in the R region of long terminal repeats in small ruminant lentiviruses is associated with decreased pathology in the lung. Vet J 2008; 175: 346-55.
68. Mercier G, Galien R, Emanoil-Ravier R. Differential effects of ras and jun family members on complex retrovirus promoter activities. Res Virol 1994; 145: 361-7.
69. Villet S, Faure C, Bouzar BA, et al. Lack of trans-activation function for Maedi Visna virus and Caprine arthritis encephalitis virus Tat proteins. Virology 2003; 307: 317-27.
70. Gatignol A, Jeang KT. Tat as a transcriptional activator and a potential therapeutic target for HIV-1. Adv Pharmacol 2000; 48: 209-27.
71. Choudhury I, Wang J, Stein S, Rabson A, Leibowitz MJ. Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1. J Gen Virol 1999; 80(Pt 3): 777-82.
72. Berkhout B, Silverman RH, Jeang KT. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 1989; 59: 273-82.
73. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol 1999; 19: 4592-9.
74. Dayton AI, Sodroski JG, Rosen CA, Goh WC, Haseltine WA. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell 1986; 44: 941-7.
75. Sherman L, Yaniv A, Lichtman-Pleban H, Tronick SR, Gazit A. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats. J Virol 1989; 63: 4925-31.
76. Saltarelli M, Querat G, Konings DA, Vigne R, Clements JE. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 1990; 179: 347-64.
77. Jackson MK, Knowles DP, Stem TA, et al. Genetic structure of the pol-env region of the caprine arthritis-encephalitis lentivirus genome. Virology 1991; 180: 389-94.
78. Kalinski H, Mashiah P, Rotem D, et al. Characterization of cDNAs species encoding the Tat protein of caprine arthritis encephalitis virus. Virology 1994; 204: 828-34.
79. Neuveut C, Vigne R, Clements JE, Sire J. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes. Virology 1993; 197: 236-44.
80. Carruth LM, Hardwick JM, Morse BA, Clements JE. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains. J Virol 1994; 68: 6137-46.
81. Gabuzda DH, Hess JL, Small JA, Clements JE. Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol Cell Biol 1989; 9: 2728-33.
82. Carruth LM, Morse BA, Clements JE. The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat. J Virol 1996; 70: 4338-44.
83. Morse BA, Carruth LM, Clements JE. Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo. J Virol 1999; 73: 37-45.
84. Hess JL, Clements JE, Narayan O. cis- and trans-acting transcriptional regulation of visna virus. Science 1985; 229: 482-5.
85. Saltarelli MJ, Schoborg R, Gdovin SL, Clements JE. The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication. Virology 1993; 197: 35-44.
86. Harmache A, Vitu C, Russo P, et al. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J Virol 1995; 69: 5445-54.
87. Blacklaws BA, Berriatua E, Torsteinsdottir S, et al. Transmission of small ruminant lentiviruses. Vet Microbiol 2004; 101: 199-208.
88. Ali Al Ahmad MZ, Fieni F, Guiguen F, et al. Cultured early goat embryos and cells are susceptible to infection with caprine encephalitis virus. Virology 2006; 353: 307-15.
89. Toth FD, Bacsi A, Beck Z, Szabo J. Vertical transmission of human immunodeficiency virus. Acta Microbiol Immunol Hung 2001; 48: 413-27.
90. Ellis JE, Hair GA, Lindsay MK, Ansari AA, Sundstrom JB. Fetal cord blood mononuclear cells that are collected at term from HIV-1 infected women harbor transcriptionally active integrated proviral DNA. Am J Obstet Gynecol 2007; 197: 371 e1-6.
91. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-tochild transmission. J Infect Dis 2004; 190: 1880-8.
92. John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr 2004; 35: 196-202.
93. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997; 3: 42-7.
94. Amerongen HM, Weltzin R, Farnet CM, et al. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr 1991; 4: 760-5.
95. Fotopoulos G, Harari A, Michetti P, et al. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci USA 2002; 99: 9410-4.
96. Alvarez V, Arranz J, Daltabuit-Test M, et al. Relative contribution of colostrum from Maedi-Visna virus (MVV) infected ewes to MVV-seroprevalence in lambs. Res Vet Sci 2005; 78: 237-43.
97. McNeilly TN, Tennant P, Lujan L, Perez M, Harkiss GD. Differential infection efficiencies of peripheral lung and tracheal tissues in sheep infected with Visna/maedi virus via the respiratory tract. J Gen Virol 2007; 88: 670-9.
98. McNeilly TN, Baker A, Brown JK, et al. Role of alveolar macrophages in respiratory transmission of visna/maedi virus. J Virol 2008; 82: 1526-36.
99. Torsteinsdottir S, Matthiasdottir S, Vidarsdottir N, Svansson V, Petursson G. Intratracheal inoculation as an efficient route of experimental infection with maedi-visna virus. Res Vet Sci 2003; 75: 245-7.
100. Niesalla H, McNeilly TN, Ross M, Rhind SM, Harkiss GD. Experimental infection of sheep with visna/maedi virus via the conjunctival space. J Gen Virol 2008; 89: 1329-37.
101. Twigg HL, Weiden M, Valentine F, et al. Effect of highly active antiretroviral therapy on viral burden in the lungs of HIV-infected subjects. J Infect Dis 2008; 197: 109-16.
102. Gonzalez OA, Ebersole JL, Huang CB. Oral infectious diseases: a potential risk factor for HIV virus recrudescence? Oral Dis 2009; 15: 313-27.
103. Ablashi DV, Sturzenegger S, Hunter EA, et al. Presence of HTLV-III in tears and cells from the eyes of AIDS patients. J Exp Pathol 1987; 3: 693-703.
104. Wolff H, Anderson DJ. Male genital tract inflammation associated with increased numbers of potential human immunodeficiency virus host cells in semen. Andrologia 1988; 20: 404-10.
105. Hansasuta P, Rowland-Jones SL. HIV-1 transmission and acute HIV-1 infection. Br Med Bull 2001; 58: 109-27.
106. Miller CJ, Shattock RJ. Target cells in vaginal HIV transmission. Microbes Infect 2003; 5: 59-67.
107. Fischetti L, Barry SM, Hope TJ, Shattock RJ. HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS 2009; 23: 319-28.
108. Ullrich R, Schmidt W, Zippel T, et al. Mucosal HIV infection. Pathobiology 1998; 66: 145-50.
109. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20: 1491-5.
110. Schwartz O. Langerhans cells lap up HIV-1. Nat Med 2007; 13: 245-6.
111. Peterson K, Brinkhof J, Houwers DJ, Colenbrander B, Gadella BM. Presence of pro-lentiviral DNA in male sexual organs and ejaculates of small ruminants. Theriogenology 2008; 69: 433-42.
112. Ali Al Ahmad MZ, Fieni F, Pellerin JL, et al. Detection of viral genomes of caprine arthritis-encephalitis virus (CAEV) in semen and in genital tract tissues of male goat. Theriogenology 2008; 69: 473-80.
113. Petursson G, Nathanson N, Georgsson G, Panitch H, Palsson PA. Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest 1976; 35: 402-12.
114. Klevjer-Anderson P, Adams DS, Anderson LW, Banks KL, McGuire TC. A sequential study of virus expression in retrovirus-induced arthritis of goats. J Gen Virol 1984; 65(Pt 9): 1519-25.
115. Niesalla H, de Andres X, Barbezange C, et al. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine 2009; 27: 260-9.
116. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989; 321: 1621-5.
117. Legoff J, Tanton C, Lecerf M, et al. Influence of storage temperature on the stability of HIV-1 RNA and HSV-2 DNA in cervicovaginal secretions collected by vaginal washing. J Virol Methods 2006; 138: 196-200.
118. Goff SP. Retroviridae: the retroviruses and their replication, p. 1999-2069. In Knipe DM, Howley PM, Eds. Fields Virology, 5 ed, Philadelphia: Lippincott, Williams & Wilkins 2007; vol. 2.
119. Villet S, Bouzar BA, Morin T, et al. Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein. J Virol 2003; 77: 9632-8.
120. Davis JL, Molineaux S, Clements JE. Visna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus. J Virol 1987; 61: 1325-31.
121. Mazarin V, Gourdou I, Querat G, Sauze N, Vigne R. Genetic structure and function of an early transcript of visna virus. J Virol 1988; 62: 4813-8.
122. Sargan DR, Roy DJ, Dalziel RG, Watt NJ, McConnell I. A temporal study of RNAs produced in maedi-visna virus infection of choroid plexus cells. Vet Microbiol 1994; 39: 369-78.
123. Kaye JF, Lever AM. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J Virol 1999; 73: 3023-31.
124. Bjarnadottir H, Gudmundsson B, Gudnason J, Jonsson JJ. Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region. J Virol 2006; 80: 11743-55.
125. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 1993; 67: 6365-78.
126. Pepin M, Vitu C, Russo P, Mornex JF, Peterhans E. Maedi-visna virus infection in sheep: a review. Vet Res 1998; 29: 341-67.
127. Querat G, Audoly G, Sonigo P, Vigne R. Nucleotide sequence analysis of SA-OMVV, a visna-related ovine lentivirus: phylogenetic history of lentiviruses. Virology 1990; 175: 434-47.
128. Valas S, Rolland M, Perrin C, Perrin G, Mamoun RZ. Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein. Retrovirology 2008; 5: 22.
129. Vigne R, Filippi P, Querat G, et al. Precursor polypeptides to structural proteins of visna virus. J Virol 1982; 42: 1046-56.
130. Schultz AM, Henderson LE, Oroszlan S. Fatty acylation of proteins. Annu Rev Cell Biol 1988; 4: 611-47.
131. Zhou W, Parent LJ, Wills JW, Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 1994; 68: 2556-69.
132. Reyburn HT, Roy DJ, Blacklaws BA, Sargan DR, McConnell I. Expression of maedi-visna virus major core protein, p25: development of a sensitive p25 antigen detection assay. J Virol Methods 1992; 37: 305-20.
133. Freed EO. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998; 251: 1-15.
134. Ott DE, Coren LV, Shatzer T. The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly. J Virol 2009; 83: 7718-27.
135. Brierley I, Dos Ramos FJ. Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. Virus Res 2006; 119: 29-42.
136. Pennell S, Manktelow E, Flatt A, et al. The stimulatory RNA of the Visna-Maedi retrovirus ribosomal frameshifting signal is an unusual pseudoknot with an interstem element. Rna 2008; 14: 1366-77.
137. Priet S, Gros N, Navarro JM, et al. HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol Cell 2005; 17: 479-90.
138. Turelli P, Petursson G, Guiguen F, et al. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol 1996; 70: 1213-7.
139. Petursson G, Turelli P, Matthiasdottir S, et al. Visna virus dUTPase is dispensable for neuropathogenicity. J Virol 1998; 72: 1657-61.
140. Turelli P, Guiguen F, Mornex JF, Vigne R, Querat G. dUTPaseminus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol 1997; 71: 4522-30.
141. Thormar H, Georgsson G, Gunnarsson E, et al. Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA). Antivir Chem Chemother 1998; 9: 245-52.
142. Thormar H, Balzarini J, Debyser Z, et al. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents. Antiviral Res 1995; 27: 49-57.
143. Gjerset B, Storset AK, Rimstad E. Genetic diversity of smallruminant lentiviruses: characterization of Norwegian isolates of Caprine arthritis encephalitis virus. J Gen Virol 2006; 87: 573-80.
144. Crane SE, Kanda P, Clements JE. Identification of the fusion domain in the visna virus transmembrane protein. Virology 1991; 185: 488-92.
145. Sanchez AB, Rodriguez D, Garzon A, et al. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans. Arch Virol 2002; 147: 2377-92.
146. Lichtensteiger CA, Knowles DP, Jr., McGuire TC, Cheevers WP. Recombinant gp135 envelope glycoproteins of caprine arthritis-encephalitis lentivirus variants inhibit homologous and heterologous variant-specific neutralizing antibodies. Virology 1991; 185: 2-9.
147. Toohey KL, Haase AT. The rev gene of visna virus is required for productive infection. Virology 1994; 200: 276-80.
148. Sargan DR, Bennet ID. A transcriptional map of visna virus: definition of the second intron structure suggests a rev-like gene product. J Gen Virol 1989; 70(Pt 8): 1995-2006.
149. Schoborg RV. Analysis of caprine arthritis encephalitis virus (CAEV) temporal gene expression in infected cells. Virus Res 2002; 90: 37-46.
150. Tiley LS, Malim MH, Tewary HK, Stockley PG, Cullen BR. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci USA 1992; 89: 758-62.
151. Tiley LS, Cullen BR. Structural and functional analysis of the visna virus Rev-response element. J Virol 1992; 66: 3609-15.
152. Meyer BE, Meinkoth JL, Malim MH. Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J Virol 1996; 70: 2350-9.
153. Mazarin V, Gourdou I, Querat G, et al. Subcellular localization of rev-gene product in visna virus-infected cells. Virology 1990; 178: 305-10.
154. Audoly G, Sauze N, Harkiss G, et al. Identification and subcellular localization of the Q gene product of visna virus. Virology 1992; 189: 734-9.
155. Kristbjornsdottir HB, Andresdottir V, Svansson V, et al. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro. Virology 2004; 318: 350-9.
156. Gudmundsson B, Jonsson SR, Olafsson O, et al. Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo. J Virol 2005; 79: 15038-42.
157. Gourdou I, Mazarin V, Querat G, Sauze N, Vigne R. The open reading frame S of visna virus genome is a trans-activating gene. Virology 1989; 171: 170-8.
158. List J, Haase AT. Integration of visna virus DNA occurs and may be necessary for productive infection. Virology 1997; 237: 189-97.
159. Harris JD, Scott JV, Traynor B, et al. Visna virus DNA: discovery of a novel gapped structure. Virology 1981; 113: 573-83.
160. Blum HE, Harris JD, Ventura P, et al. Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna. Virology 1985; 142: 270-7.
161. Clements JE, Narayan O, Griffin DE, Johnson RT. The synthesis and structure of visna virus DNA. Virology 1979; 93: 377-86.
162. Monie TP, Greatorex JS, Maynard-Smith L, et al. Identification and visualization of the dimerization initiation site of the prototype lentivirus, maedi visna virus: a potential GACG tetraloop displays structural homology with the alpha- and gamma-retroviruses. Biochemistry 2005; 44: 294-302.
163. Brahic M, Vigne R. Properties of Visna Virus Particles Harvested at Short Time Intervals: RNA Content, Infectivity, and Ultrastructure. J Virol 1975; 15: 1222-30.
164. Jewell NA, Mansky LM. In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J Gen Virol 2000; 81: 1889-99.
165. Lee WC, McConnell I, Blacklaws BA. Electron microscope studies of the replication of a British isolate of maedi visna virus in macrophages and skin cell lines. Vet Microbiol 1996; 49: 93-104.
166. Narayan O, Clements JE, Strandberg JD, Cork LC, Griffin DE. Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol 1980; 50: 69-79.
167. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988; 62: 2578-86.
168. Finzi A, Orthwein A, Mercier J, Cohen EA. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J Virol 2007; 81: 7476-90.
169. Resh MD. Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles. AIDS Rev 2005; 7: 84-91.
170. Cadore JL, Greenland T, Cordier G, Guiguen F, Mornex JF. Histogenesis of the pulmonary lesions in the course of visna maedi virus-induced pneumonia. Vet Res 1996; 27: 419-26.
171. Cadore JL, Loubeyre P, Vuillermoz S, et al. Early diagnosis of lentivirus-induced infiltrative lung disease in sheep by high resolution computed tomography. Eur Respir J 1997; 10: 1456-9.
172. Mankowski JL, Carter DL, Spelman JP, et al. Pathogenesis of simian immunodeficiency virus pneumonia: an immunopathological response to virus. Am J Pathol 1998; 153: 1123-30.
173. Pantaleo G, Fauci AS. Immunopathogenesis of HIV infection. Annu Rev Microbiol 1996; 50: 825-54.
174. Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17: 21-4.
175. Shacklett BL. Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals. Curr HIV/AIDS Rep 2006; 3: 26-31.
176. Benavides J, Garcia-Pariente C, Ferreras MC, et al. Diagnosis of clinical cases of the nervous form of Maedi-Visna in 4- and 6-month-old lambs. Vet J 2007; 174: 655-8.
177. Trujillo JD, Hotzel KJ, Snekvik KR, Cheevers WP. Antibody response to the surface envelope of caprine arthritis-encephalitis lentivirus: disease status is predicted by SU antibody isotype. Virology 2004; 325: 129-36.
178. Herrmann-Hoesing LM, Palmer GH, Knowles DP. Evidence of proviral clearance following postpartum transmission of an ovine lentivirus. Virology 2007; 362: 226-34.
179. Allison RW, Hoover EA. Covert vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 2003; 19: 421-34.
180. Tasca S, Tsai L, Trunova N, et al. Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure. Virology 2007; 367: 196-211.
181. Assogba BD, Leavell S, Porter K, Burkhard MJ. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency. J Infect Dis 2007; 195: 1184-8.
182. Ruprecht RM, Baba TW, Rasmussen R, Hu Y, Sharma PL. Murine and simian retrovirus models: the threshold hypothesis. AIDS 1996; 10(Suppl A): S33-40.
183. Georgsson G, Martin JR, Klein J, et al. Primary demyelination in visna. An ultrastructural study of Icelandic sheep with clinical signs following experimental infection. Acta Neuropathol 1982; 57: 171-8.
184. Nathanson N, Georgsson G, Palsson PA, et al. Experimental visna in Icelandic sheep: the prototype lentiviral infection. Rev Infect Dis 1985; 7: 75-82.
185. Sundquist B, Jonsson L, Jacobsson SO, Hammarberg KE. Visna virus meningoencephalomyelitis in goats. Acta Vet Scand 1981; 22: 315-30.
186. Georgsson G. Neuropathologic aspects of lentiviral infections. Ann N Y Acad Sci 1994; 724: 50-67.
187. Georgsson G, Palsson PA. The histopathology of maedi a slow, viral pneumonia of sheep. Vet Pathol 1971; 8: 63-80.
188. Cutlip RC, Jackson TA, Laird GA. Prevalence of ovine progressive pneumonia in a sampling of cull sheep from western and midwestern United States. Am J Vet Res 1977; 38: 2091-3.
189. Oliver RE, Gorham JR, Perryman LE, Spencer GR. Ovine progressive pneumonia: experimental intrathoracic, intracerebral, and intra-articular infections. Am J Vet Res 1981; 42: 1560-4.
190. Mornex JF, Lena P, Loire R, et al. Lentivirus-induced interstitial lung disease: pulmonary pathology in sheep naturally infected by the visna-maedi virus. Vet Res 1994; 25: 478-88.
191. Cadore JL, Guiguen F, Cordier G, et al. Early events in the experimental interstitial lung disease induced in sheep by the Visna-maedi virus. Immunol Lett 1993; 39: 39-43.
192. van der Molen EJ, Houwers DJ. Indurative lymphocytic mastitis in sheep after experimental infection with maedivisna virus. Vet Q 1987; 9: 193-202.
193. Lairmore MD, Poulson JM, Adducci TA, DeMartini JC. Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains. Am J Pathol 1988; 130: 80-90.
194. Watt NJ, MacIntyre N, Collie D, Sargan D, McConnell I. Phenotypic analysis of lymphocyte populations in the lungs and regional lymphoid tissue of sheep naturally infected with maedi visna virus. Clin Exp Immunol 1992; 90: 204-8.
195. Cordier G, Guiguen F, Cadore JL, et al. Characterization of the lymphocytic alveolitis in visna-maedi virus-induced interstitial lung disease of sheep. Clin Exp Immunol 1992; 90: 18-24.
196. Lujan L, Begara I, Collie DD, Watt NJ. CD8+ lymphocytes in bronchoalveolar lavage and blood: in vivo indicators of lung pathology caused by maedi-visna virus. Vet Immunol Immunopathol 1995; 49: 89-100.
197. Begara I, Lujan L, Hopkins J, et al. A study on lymphocyte activation in maedi-visna virus induced pneumonia. Vet Immunol Immunopathol 1995; 45: 197-210.
198. Brodie SJ, Pearson LD, Snowder GD, DeMartini JC. Host-virus interaction as defined by amplification of viral DNA and serology in lentivirus-infected sheep. Arch Virol 1993; 130: 413-28.
199. Lujan L, Begara I, Collie D, Watt NJ. Ovine lentivirus (maedivisna virus) protein expression in sheep alveolar macrophages. Vet Pathol 1994; 31: 695-703.
200. Begara I, Lujan L, Collie DD, Miller HR, Watt NJ. Early pulmonary cell response during experimental maedi-visna virus infection. Vet Immunol Immunopathol 1996; 55: 115-26.
201. Storset AK, Evensen O, Rimstad E. Immunohistochemical identification of caprine arthritis-encephalitis virus in paraffinembedded specimens from naturally infected goats. Vet Pathol 1997; 34: 180-8.
202. Lairmore MD, Rosadio RH, DeMartini JC. Ovine lentivirus lymphoid interstitial pneumonia. Rapid induction in neonatal lambs. Am J Pathol 1986; 125: 173-81.
203. Zar HJ. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol 2008; 43: 1-10.
204. Theron S, Andronikou S, George R, et al. Non-infective pulmonary disease in HIV-positive children. Pediatr Radiol 2009; 39: 555-64.
205. Das S, Miller RF. Lymphocytic interstitial pneumonitis in HIV infected adults. Sex Transm Infect 2003; 79: 88-93.
206. Marks MJ, Haney PJ, McDermott MP, White CS, Vennos AD. Thoracic disease in children with AIDS. Radiographics 1996; 16: 1349-62.
207. Marquis JR, Berman CZ, DiCarlo F, Oleske JM. Radiographic patterns of PLH/LIP in HIV positive children. Pediatr Radiol 1993; 23: 328-30.
208. Jeanes AC, Owens CM. Chest imaging in the immunocompromised child. Paediatr Respir Rev 2002; 3: 59-69.
209. Ambrosino MM, Roche KJ, Genieser NB, Kaul A, Lawrence RM. Application of thin-section low-dose chest CT (TSCT) in the management of pediatric AIDS. Pediatr Radiol 1995; 25: 393-400.
210. Rabie H, de Boer A, van den Bos S, et al. Children with human immunodeficiency virus infection admitted to a paediatric intensive care unit in South Africa. J Trop Pediatr 2007; 53: 270-3.
211. Berman DM, Mafut D, Djokic B, Scott G, Mitchell C. Risk factors for the development of bronchiectasis in HIV-infected children. Pediatr Pulmonol 2007; 42: 871-5.
212. Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996; 2: 429-33.
213. Guillon JM, Autran B, Denis M, et al. Human immunodeficiency virus-related lymphocytic alveolitis. Chest 1988; 94: 1264-70.
214. Midulla F, Strappini P, Sandstrom T, et al. Cellular and noncellular components of bronchoalveolar lavage fluid in HIV-1-infected children with radiological evidence of interstitial lung damage. Pediatr Pulmonol 2001; 31: 205-13.
215. Itescu S, Brancato LJ, Winchester R. A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 2: 466-8.
216. Griffiths MH, Miller RF, Semple SJ. Interstitial pneumonitis in patients infected with the human immunodeficiency virus. Thorax 1995; 50: 1141-6.
217. Miller RF, Pugsley WB, Griffiths MH. Open lung biopsy for investigation of acute respiratory episodes in patients with HIV infection and AIDS. Genitourin Med 1995; 71: 280-5.
218. Dufour V, Wislez M, Bergot E, Mayaud C, Cadranel J. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2003; 36: e127-30.
219. Twigg HL, Knox KS. HIV-Related Lung Disorders. Drug Discov Today Dis Mech 2007; 4: 95-101.
220. Ingiliz P, Appenrodt B, Gruenhage F, et al. Lymphoid pneumonitis as an immune reconstitution inflammatory syndrome in a patient with CD4 cell recovery after HAART initiation. HIV Med 2006; 7: 411-4.
221. Naccache JM, Antoine M, Wislez M, et al. Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 1999; 159: 2009-13.
222. Georgsson G, Palsson PA, Panitch H, Nathanson N, Petursson G. The ultrastructure of early visna lesions. Acta Neuropathol 1977; 37: 127-35.
223. Benavides J, Garcia-Pariente C, Fuertes M, et al. Maedi-visna: the meningoencephalitis in naturally occurring cases. J Comp Pathol 2009; 140: 1-11.
224. Torsteinsdottir S, Georgsson G, Gisladottir E, et al. Pathogenesis of central nervous system lesions in visna: cell-mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid. J Neuroimmunol 1992; 41: 149-58.
225. Biescas E, Preziuso S, Bulgin M, DeMartini JC. Ovine lentivirus- associated leucomyelitis in naturally infected North American sheep. J Comp Pathol 2005; 132: 107-16.
226. Benavides J, Fuertes M, Garcia-Pariente C, et al. Natural cases of visna in sheep with myelitis as the sole lesion in the central nervous system. J Comp Pathol 2006; 134: 219-30.
227. Benavides J, Gomez N, Gelmetti D, et al. Diagnosis of the nervous form of Maedi-Visna infection with a high frequency in sheep in Castilla y Leon, Spain. Vet Rec 2006; 158: 230-5.
228. Bergsteinsdottir K, Arnadottir S, Torsteinsdottir S, et al. Constitutive and visna virus induced expression of class I and II major histocompatibility complex antigens in the central nervous system of sheep and their role in the pathogenesis of visna lesions. Neuropathol Appl Neurobiol 1998; 24: 224-32.
229. Haase AT, Stowring L, Narayan P, Griffin D, Price D. Slow persistent infection caused by visna virus: role of host restriction. Science 1977; 195: 175-7.
230. Brahic M, Stowring L, Ventura P, Haase AT. Gene expression in visna virus infection in sheep. Nature 1981; 292: 240-2.
231. Geballe AP, Ventura P, Stowring L, Haase AT. Quantitative analysis of visna virus replication in vivo. Virology 1985; 141: 148-54.
232. Tomlinson GS, Simmonds P, Busuttil A, Chiswick A, Bell JE. Upregulation of microglia in drug users with and without presymptomatic HIV infection. Neuropathol Appl Neurobiol 1999; 25: 369-79.
233. Bell JE, Busuttil A, Ironside JW, et al. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993; 168: 818-24.
234. Bell JE, Donaldson YK, Lowrie S, et al. Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 1996; 10: 493-9.
235. Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain 2003; 126: 1058-67.
236. Lentz MR, Kim WK, Lee V, et al. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 2009; 72: 1465-72.
237. Lang W, Miklossy J, Deruaz JP, et al. Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol 1989; 77: 379-90.
238. Gray F, Scaravilli F, Everall I, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996; 6: 1-15.
239. Everall IP, Hansen LA, Masliah E. The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 2005; 8: 51-61.
240. King JE, Eugenin EA, Buckner CM, Berman JW. HIV tat and neurotoxicity. Microbes Infect 2006; 8: 1347-57.
241. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998; 121(Pt 11): 2043-52.
242. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20: 15-24.
243. Shepherd EJ, Brettle RP, Liberski PP, et al. Spinal cord pathology and viral burden in homosexuals and drug users with AIDS. Neuropathol Appl Neurobiol 1999; 25: 2-10.
244. Budka H, Costanzi G, Cristina S, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987; 75: 185-98.
245. Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986; 19: 525-35.
246. Tyor WR, Glass JD, Griffin JW, et al. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 1992; 31: 349-60.
247. Weidenheim KM, Epshteyn I, Lyman WD. Immunocytochemical identification of T-cells in HIV-1 encephalitis: implications for pathogenesis of CNS disease. Mod Pathol 1993; 6: 167-74.
248. Falangola MF, Hanly A, Galvao-Castro B, Petito CK. HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J Neuropathol Exp Neurol 1995; 54: 497-503.
249. Katsetos CD, Fincke JE, Legido A, et al. Angiocentric CD3(+) Tcell infiltrates in human immunodeficiency virus type 1-associated central nervous system disease in children. Clin Diagn Lab Immunol 1999; 6: 105-14.
250. Cosenza-Nashat MA, Kim MO, Zhao ML, Suh HS, Lee SC. CD45 isoform expression in microglia and inflammatory cells in HIV-1 encephalitis. Brain Pathol 2006; 16: 256-65.
251. Petito CK, Adkins B, McCarthy M, Roberts B, Khamis I. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 2003; 9: 36-44.
252. Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003; 62: 429-40.
253. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64: 529-36.
254. Hult B, Chana G, Masliah E, Everall I. Neurobiology of HIV. Int Rev Psychiatry 2008; 20: 3-13.
255. Langford TD, Letendre SL, Larrea GJ, Masliah E. Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 2003; 13: 195-210.
256. Ammassari A, Cingolani A, Pezzotti P, et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 2000; 55: 1194-200.
257. Langford TD, Letendre SL, Marcotte TD, et al. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 2002; 16: 1019-29.
258. Petito CK, Torres-Munoz JE, Zielger F, McCarthy M. Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J Neurovirol 2006; 12: 272-83.
259. van der Molen EJ, Vecht U, Houwers DJ. A chronic indurative mastitis in sheep, associated with maedi/visna virus infection. Vet Q 1985; 7: 112-9.
260. Kennedy-Stoskopf S, Narayan O, Strandberg JD. The mammary gland as a target organ for infection with caprine arthritis-encephalitis virus. J Comp Pathol 1985; 95: 609-17.
261. Pekelder JJ, Veenink GJ, Akkermans JP, et al. Ovine lentivirus induced indurative lymphocytic mastitis and its effect on the growth of lambs. Vet Rec 1994; 134: 348-50.
262. Cutlip RC, Lehmkuhl HD, Brogden KA, Bolin SR. Mastitis associated with ovine progressive pneumonia virus infection in sheep. Am J Vet Res 1985; 46: 326-8.
263. Lujan L, Garcia Marin JF, Fernandez de Luco D, Vargas A, Badiola JJ. Pathological changes in the lungs and mammary glands of sheep and their relationship with maedi-visna infection. Vet Rec 1991; 129: 51-4.
264. Bolea R, Monleon E, Carrasco L, et al. Maedi-visna virus infection of ovine mammary epithelial cells. Vet Res 2006; 37: 133-44.
265. Leroux C, Lerondelle C, Chastang J, Mornex JF. RT-PCR detection of lentiviruses in milk or mammary secretions of sheep or goats from infected flocks. Vet Res 1997; 28: 115-21.
266. Russo P, Vitu C, Bourgogne A, et al. Caprine arthritis- encephalitis virus: detection of proviral DNA in lactoserum cells. Vet Rec 1997; 140: 483-4.
267. Sanchez A, Contreras A, Corrales JC, Marco JC. Relationships between infection with caprine arthritis encephalitis virus, intramammary bacterial infection and somatic cell counts in dairy goats. Vet Rec 2001; 148: 711-4.
268. Luengo C, Sanchez A, Corrales JC, Fernandez C, Contreras A. Influence of intramammary infection and non-infection factors on somatic cell counts in dairy goats. J Dairy Res 2004; 71: 169-74.
269. Ouzrout R, Guiguen F, Lerondelle C. [Development of lymphocyte subsets in milk from ewes excreting Maedi virus]. Ann Rech Vet 1991; 22: 379-86.
270. Mselli-Lakhal L, Guiguen F, Fornazero C, et al. Goat milk epithelial cells are highly permissive to CAEV infection in vitro. Virology 1999; 259: 67-73.
271. Klassen MK, Lewin-Smith M, Frankel SS, Nelson AM. Pathology of human immunodeficiency virus infection: noninfectious conditions. Ann Diagn Pathol 1997; 1: 57-64.
272. Pantanowitz L, Connolly JL. Pathology of the breast associated with HIV/AIDS. Breast J 2002; 8: 234-43.
273. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999; 180: 93-8.
274. Konstantinopoulos PA, Dezube BJ, March D, Pantanowitz L. HIV-associated intramammary lymphadenopathy. Breast J 2007; 13: 192-5.
275. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 1993; 341: 914-8.
276. Southern SO. Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol 1998; 1: 328-37.
277. Petitjean G, Becquart P, Tuaillon E, et al. Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk. J Clin Virol 2007; 39: 1-8.
278. Satomi M, Shimizu M, Shinya E, et al. Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DCSIGN. J Infect Dis 2005; 191: 174-81.
279. Toniolo A, Serra C, Conaldi PG, et al. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 1995; 9: 859-66.
280. Tuaillon E, Valea D, Becquart P, et al. Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies. J Immunol 2009; 182: 7155-62.
281. Sabbaj S, Edwards BH, Ghosh MK, et al. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol 2002; 76: 7365-73.
282. Kourtis AP, Ibegbu CC, Theiler R, et al. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J Infect Dis 2007; 195: 965-72.
283. Lohman BL, Slyker J, Mbori-Ngacha D, et al. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. J Infect Dis 2003; 188: 1666-74.
284. Sabbaj S, Ghosh MK, Edwards BH, et al. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005; 174: 2951-6.
285. Woodard JC, Gaskin JM, Poulos PW, MacKay RJ, Burridge MJ. Caprine arthritis-encephalitis: clinicopathologic study. Am J Vet Res 1982; 43: 2085-96.
286. Cutlip RC, Lehmkuhl HD, Wood RL, Brogden KA. Arthritis associated with ovine progressive pneumonia. Am J Vet Res 1985; 46: 65-8.
287. Kennedy-Stoskopf S, Zink MC, Jolly PE, Narayan O. Lentivirus-induced arthritis. Chronic disease caused by a covert pathogen. Rheum Dis Clin North Am 1987; 13: 235-47.
288. Narayan O, Zink MC, Gorrell M, et al. Lentivirus induced arthritis in animals. J Rheumatol Suppl 1992; 32: 25-32; discussion -4.
289. Wilkerson MJ, Davis WC, Baszler TV, Cheevers WP. Immunopathology of chronic lentivirus-induced arthritis. Am J Pathol 1995; 146: 1433-43.
290. Crawford TB, Adams DS, Sande RD, Gorham JR, Henson JB. The connective tissue component of the caprine arthritis-encephalitis syndrome. Am J Pathol 1980; 100: 443-54.
291. Harkiss GD, Green C, Anderson A, Watt NJ. Immunoglobulin deposits in synovial membrane and cartilage and phenotype analysis of chondrocyte antigens in sheep infected with the visna retrovirus. Rheumatol Int 1995; 15: 15-22.
292. Cheevers WP, McGuire TC. The lentiviruses: maedi/visna, caprine arthritis-encephalitis, and equine infectious anemia. Adv Virus Res 1988; 34: 189-215.
293. Kennedy-Stoskopf S, Zink C, Narayan O. Pathogenesis of ovine lentivirus-induced arthritis: phenotypic evaluation of T lymphocytes in synovial fluid, synovium, and peripheral circulation. Clin Immunol Immunopathol 1989; 52: 323-30.
294. Wilkerson MJ, Davis WC, Cheevers WP. Peripheral blood and synovial fluid mononuclear cell phenotypes in lentivirus induced arthritis. J Rheumatol 1995; 22: 8-15.
295. Harkiss GD, Watt NJ, King TJ, Williams J, Hopkins J. Retroviral arthritis: phenotypic analysis of cells in the synovial fluid of sheep with inflammatory synovitis associated with visna virus infection. Clin Immunol Immunopathol 1991; 60: 106-17.
296. Anderson AA, Harkiss GD, Watt NJ. Quantitative analysis of immunohistological changes in the synovial membrane of sheep infected with Maedi-Visna virus. Clin Immunol Immunopathol 1994; 72: 21-9.
297. Johnson GC, Adams DS, McGuire TC. Pronounced production of polyclonal immunoglobulin G1 in the synovial fluid of goats with caprine arthritis-encephalitis virus infection. Infect Immun 1983; 41: 805-15.
298. Johnson GC, Barbet AF, Klevjer-Anderson P, McGuire TC. Preferential immune response to virion surface glycoproteins by caprine arthritis- encephalitis virus-infected goats. Infect Immun 1983; 41: 657-65.
299. Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol 2003; 17: 265-87.
300. Yao Q, Frank M, Glynn M, Altman RD. Rheumatic manifestations in HIV-1 infected in-patients and literature review. Clin Exp Rheumatol 2008; 26: 799-806.
301. Walker UA, Tyndall A, Daikeler T. Rheumatic conditions in human immunodeficiency virus infection. Rheumatology (Oxford) 2008; 47: 952-9.
302. Rowe IF. Arthritis in the acquired immunodeficiency syndrome and other viral infections. Curr Opin Rheumatol 1991; 3: 621-7.
303. Medina-Rodriguez F, Guzman C, Jara LJ, et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol 1993; 20: 1880-4.
304. Reveille JD. The changing spectrum of rheumatic disease in human immunodeficiency virus infection. Semin Arthritis Rheum 2000; 30: 147-66.
305. Chinniah K, Mody GM, Bhimma R, Adhikari M. Arthritis in association with human immunodeficiency virus infection in Black African children: causal or coincidental? Rheumatology (Oxford) 2005; 44: 915-20.
306. Bentin J, Feremans W, Pasteels JL, et al. Chronic acquired immunodeficiency syndrome-associated arthritis: a synovial ultrastructural study. Arthritis Rheum 1990; 33: 268-73.
307. Espinoza LR, Aguilar JL, Espinoza CG, et al. HIV associated arthropathy: HIV antigen demonstration in the synovial membrane. J Rheumatol 1990; 17: 1195-201.
308. Reveille JD, Williams FM. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 2006; 20: 1159-79.
309. Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008; 10: 215.
310. Angelopoulou K, Brellou GD, Vlemmas I. Detection of maedivisna virus in the kidneys of naturally infected sheep. J Comp Pathol 2006; 134: 329-35.
311. Fabian J, Katz I, Gerntholtz T, Goetsch S, Naicker S. Chronic kidney disease in human immunodeficiency virus infection. Panminerva Med 2007; 49: 51-66.
312. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al. HIV-associated immune-mediated renal disease. Kidney Int 1993; 44: 1327-40.
313. Fine DM, Perazella MA, Lucas GM, Atta MG. Kidney biopsy in HIV: beyond HIV-associated nephropathy. Am J Kidney Dis 2008; 51: 504-14.
314. Nochy D, Glotz D, Dosquet P, et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993; 8: 11-9.
315. Brellou GD, Angelopoulou K, Poutahidis T, Vlemmas I. Detection of maedi-visna virus in the liver and heart of naturally infected sheep. J Comp Pathol 2007; 136: 27-35.
316. Housset C, Lamas E, Courgnaud V, et al. Presence of HIV-1 in human parenchymal and non-parenchymal liver cells in vivo. J Hepatol 1993; 19: 252-8.
317. Sudano I, Spieker LE, Noll G, et al. Cardiovascular disease in HIV infection. Am Heart J 2006; 151: 1147-55.
318. Lo J, Grinspoon S. Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk? Curr Opin HIV AIDS 2008; 3: 207-13.
319. Capucchio MT, Sanna E, Sanna MP, et al. Maedi-visna virus detection in ovine third eyelids. J Comp Pathol 2003; 129: 37-43.
320. Narayan O, Kennedy-Stoskopf S, Zink MC. Lentivirus-host interactions: lessons from visna and caprine arthritis-encephalitis viruses. Ann Neurol 1988; 23(Suppl): S95-100.
321. Petursson G, Palsson PA, Georgsson G. Maedi-visna in sheep: host-virus interactions and utilization as a model. Intervirology 1989; 30(Suppl 1): 36-44.
322. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 2007; 178: 6581-9.
323. Dong C, Kwas C, Wu L. Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 2009; 83: 3518-27.
324. Liou LY, Herrmann CH, Rice AP. Transient induction of cyclin T1 during human macrophage differentiation regulates human immunodeficiency virus type 1 Tat transactivation function. J Virol 2002; 76: 10579-87.
325. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274: 985-9.
326. Spiegel H, Herbst H, Niedobitek G, Foss HD, Stein H. Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ Thelper cells. Am J Pathol 1992; 140: 15-22.
327. Smith BA, Gartner S, Liu Y, et al. Persistence of infectious HIV on follicular dendritic cells. J Immunol 2001; 166: 690-6.
328. Lichtensteiger CA, Cheevers WP, Davis WC. CD8+ cytotoxic T lymphocytes against antigenic variants of caprine arthritis-encephalitis virus. J Gen Virol 1993; 74(Pt 10): 2111-6.
329. Blacklaws BA, Bird P, Allen D, McConnell I. Circulating cytotoxic T lymphocyte precursors in maedi-visna virus-infected sheep. J Gen Virol 1994; 75(Pt 7): 1589-96.
330. Lee WC, McConnell I, Blacklaws BA. Cytotoxic activity against maedi-visna virus-infected macrophages. J Virol 1994; 68: 8331-8.
331. Wu C, Barbezange C, McConnell I, Blacklaws BA. Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes. J Gen Virol 2008; 89: 2586-96.
332. Williams KC, Burdo TH. HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis. APMIS 2009; 117: 400-12.
333. Li Y, Li X, Stremlau M, Lee M, Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol 2006; 80: 6738-44.
334. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418: 646-50.
335. Madani N, Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol 1998; 72: 10251-5.
336. Jonsson SR, Hache G, Stenglein MD, et al. Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins. Nucleic Acids Res 2006; 34: 5683-94.
337. Harmache A, Russo P, Guiguen F, et al. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 1996; 224: 246-55.
338. Narayan O, Cork LC. Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Rev Infect Dis 1985; 7: 89-98.
339. Zink MC, Narayan O. Lentivirus-induced interferon inhibits maturation and proliferation of monocytes and restricts the replication of caprine arthritis-encephalitis virus. J Virol 1989; 63: 2578-84.
340. Juste RA, Ott TL, Kwang J, Bazer FW, de La Concha-Bermejillo A. Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J Gen Virol 2000; 81: 525-32.
341. Gendelman HE, Skillman DR, Meltzer MS. Interferon alpha (IFN)-macrophage interactions in human immunodeficiency virus (HIV) infection: role of IFN in the tempo and progression of HIV disease. Int Rev Immunol 1992; 8: 43-54.
342. Francis ML, Meltzer MS, Gendelman HE. Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Res Hum Retroviruses 1992; 8: 199-207.
343. Imbeault M, Ouellet M, Tremblay MJ. Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells. Retrovirology 2009; 6: 5.
344. Lehmann C, Taubert D, Jung N, et al. Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patients. AIDS Res Hum Retroviruses 2009; 25: 577-81.
345. Brenner BG, Dascal A, Margolese RG, Wainberg MA. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J Leukoc Biol 1989; 46: 75-83.
346. Iannello A, Debbeche O, Samarani S, Ahmad A. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J Leukoc Biol 2008; 84: 1-26.
347. Alter G, Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med 2009; 265: 29-42.
348. Singh I, McConnell I, Dalziel R, Blacklaws BA. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity. Vet Immunol Immunopathol 2006; 113: 357-66.
349. Montefiori DC, Morris L, Ferrari G, Mascola JR. Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination. Curr Opin HIV AIDS 2007; 2: 169-76.
350. Furci L, Beretta A, Siccardi A, et al. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects. AIDS Res Hum Retroviruses 1997; 13: 1461-9.
351. De Maria A, Cirillo C, Moretta L. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers. J Infect Dis 1994; 170: 1296-9.
352. Clerici M, Barassi C, Devito C, et al. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 2002; 16: 1731-41.
353. Eriksson K, McInnes E, Ryan S, et al. CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology 1999; 258: 355-64.
354. Fust G. Enhancing antibodies in HIV infection. Parasitology 1997; 115(Suppl): S127-40.
355. Subbramanian RA, Xu J, Toma E, et al. Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and - inhibiting antibodies in AIDS patients. J Clin Microbiol 2002; 40: 2141-6.
356. Beck Z, Prohaszka Z, Fust G. Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development. Vaccine 2008; 26: 3078-85.
357. Green JA, Martin EM, Mullen BT, et al. Immune-specific immunoglobulin G-mediated enhancement of human immunodeficiency virus-induced IFN-alpha production. J Interferon Cytokine Res 2002; 22: 1201-8.
358. Clerici M, Shearer GM. A TH1 - >TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107-11.
359. Tanaka M, Hirabayashi Y, Gatanaga H, et al. Reduction in interleukin-2-producing cells but not Th1 to Th2 shift in moderate and advanced stages of human immunodeficiency virus type-1-infection: direct analysis of intracellular cytokine concentrations in CD4+ CD8- T cells. Scand J Immunol 1999; 50: 550-4.
360. Imami N, Pires A, Hardy G, et al. A balanced type 1/type 2 response is associated with long-term nonprogressive human immunodeficiency virus type 1 infection. J Virol 2002; 76: 9011-23.
361. Cheevers WP, Beyer JC, Knowles DP. Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 1997; 71: 6259-63.
362. Lechner F, Vogt HR, Seow HF, et al. Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997; 151: 1053-65.
363. Ferre AL, Hunt PW, Critchfield JW, et al. Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood 2009; 113: 3978-89.
364. Krowka J, Stites D, Debs R, et al. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1. J Immunol 1990; 144: 2535-40.
365. Wahren B, Morfeldt-Mansson L, Biberfeld G, et al. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol 1987; 61: 2017-23.
366. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989; 84: 1892-9.
367. Boasso A, Shearer GM. Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol 2008; 126: 235-42.
368. Weiss L, Donkova-Petrini V, Caccavelli L, et al. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 2004; 104: 3249-56.
369. Pyrah IT, Watt NJ. Immunohistological study of the depressed cutaneous DTH response in sheep naturally infected with an ovine lentivirus (Maedi-Visna virus). Clin Exp Immunol 1996; 104: 32-6.
370. Perry LL, Wilkerson MJ, Hullinger GA, Cheevers WP. Depressed CD4+ T lymphocyte proliferative response and enhanced antibody response to viral antigen in chronic lentivirus-induced arthritis. J Infect Dis 1995; 171: 328-34.
371. Reina R, Glaria I, Benavides J, et al. Association of CD80 and CD86 expression levels with disease status of Visna/Maedi virus infected sheep. Viral Immunol 2007; 20: 609-22.
372. Begara I, Lujan L, Collie DS, Miller HR, Watt NJ. In vitro response of lymphocytes from bronchoalveolar lavage fluid and peripheral blood to mitogen stimulation during natural maedi-visna virus infection. Vet Immunol Immunopathol 1995; 49: 75-88.
373. Ubol S, Aiamkitsumrit B, Nitayaphan S, Sirinavin S, Kitthawee S. Detection of the impairment of CD80 expression on circulating monocytes in HIV-infected Thai children. Microbiol Immunol 2004; 48: 557-60.
374. Low P, Weber C, Harrer E, et al. CD80 expression on monocytes in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 15: 264-8.
375. Dudhane A, Conti B, Orlikowsky T, et al. Monocytes in HIV type 1-infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 1996; 12: 885-92.
376. Chaudhry A, Das SR, Hussain A, et al. The Nef protein of HIV-1 induces loss of cell surface costimulatory molecules CD80 and CD86 in APCs. J Immunol 2005; 175: 4566-74.
377. Miura T, Brockman MA, Schneidewind A, et al. HLAB57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition. J Virol 2009; 83: 2743-55.
378. Kaslow RA, Dorak T, Tang JJ. Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 2005; 191 (Suppl 1): S68-77.
379. Itescu S, Mathur-Wagh U, Skovron ML, et al. HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 1992; 5: 37-45.
380. Tang J, Costello C, Keet IP, et al. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1999; 15: 317-24.
381. Ruff G, Lazary S. Evidence for linkage between the caprine leucocyte antigen (CLA) system and susceptibility to CAE virus-induced arthritis in goats. Immunogenetics 1988; 28: 303-9.
382. Herrmann-Hoesing LM, White SN, Mousel MR, Lewis GS, Knowles DP. Ovine progressive pneumonia provirus levels associate with breed and Ovar-DRB1. Immunogenetics 2008; 60: 749-58.
383. Martin MP, Qi Y, Gao X, et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007; 39: 733-40.
384. Houwers DJ, Visscher AH, Defize PR. Importance of ewe/lamb relationship and breed in the epidemiology of maedi-visna virus infections. Res Vet Sci 1989; 46: 5-8.
385. Cutlip RC, Lehmkuhl HD, Brogden KA, Sacks JM. Breed susceptibility to ovine progressive pneumonia (maedi/visna) virus. Vet Microbiol 1986; 12: 283-8.
386. Gates NL, Winward LD, Gorham JR, Shen DT. Serologic survey of prevalence of ovine progressive pneumonia in Idaho range sheep. J Am Vet Med Assoc 1978; 173: 1575-7.
387. Snowder GD, Gates NL, Glimp HA, Gorham JR. Prevalence and effect of subclinical ovine progressive pneumonia virus infection on ewe wool and lamb production. J Am Vet Med Assoc 1990; 197: 475-9.
388. de la Concha-Bermejillo A, Brodie SJ, Magnus-Corral S, Bowen RA, DeMartini JC. Pathologic and serologic responses of isogeneic twin lambs to phenotypically distinct lentiviruses. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 116-23.
389. Kaur G, Mehra N. Genetic determinants of HIV-1 infection and progression to AIDS: susceptibility to HIV infection. Tissue Antigens 2009; 73: 289-301.
390. White SN, Mousel MR, Reynolds JO, Lewis GS, Herrmann-Hoesing LM. Common promoter deletion is associated with 3.9-fold differential transcription of ovine CCR5 and reduced proviral level of ovine progressive pneumonia virus. Anim Genet 2009; 40(5): 583-9.
391. Lutley R, Petursson G, Palsson PA, et al. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol 1983; 64 (Pt 7): 1433-40.
392. McGuire TC, Norton LK, O'Rourke KI, Cheevers WP. Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis. J Virol 1988; 62: 3488-92.
393. Cheevers WP, Cordery-Cotter R, McGuire TC, DeMartini JC. Neutralizing antibody responses and evolution of antigenic variants in monozygotic twin lambs infected with phenotypically distinct ovine lentiviruses. Virology 1999; 258: 382-8.
394. Andresdottir V, Skraban R, Matthiasdottir S, et al. Selection of antigenic variants in maedi-visna virus infection. J Gen Virol 2002; 83: 2543-51.
395. Klenerman P, Wu Y, Phillips R. HIV: current opinion in escapology. Curr Opin Microbiol 2002; 5: 408-13.
396. Frost SD, Trkola A, Gunthard HF, Richman DD. Antibody responses in primary HIV-1 infection. Curr Opin HIV AIDS 2008; 3: 45-51.
397. Ramirez BC, Simon-Loriere E, Galetto R, Negroni M. Implications of recombination for HIV diversity. Virus Res 2008; 134: 64-73.
398. Potter SJ, Lemey P, Achaz G, et al. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J Leukoc Biol 2004; 76: 562-70.
399. Pisoni G, Moroni P, Turin L, Bertoni G. Compartmentalization of small ruminant lentivirus between blood and colostrum in infected goats. Virology 2007; 369: 119-30.
400. Tersmette M, Lange JM, de Goede RE, et al. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 1989; 1: 983-5.
401. Schuitemaker H, Kootstra NA, de Goede RE, et al. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol 1991; 65: 356-63.
402. Wood N, Bhattacharya T, Keele BF, et al. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 2009; 5: e1000414.
403. Saksena NK, Rodes B, Wang B, Soriano V. Elite HIV controllers: myth or reality? AIDS Rev 2007; 9: 195-207.
404. Bird P, Blacklaws B, Reyburn HT, et al. Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol 1993; 67: 5187-97.
405. Nathanson N, Panitch H, Palsson PA, Petursson G, Georgsson G. Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest 1976; 35: 444-51.
406. Nathanson N, Martin JR, Georgsson G, et al. The effect of post-infection immunization on the severity of experimental visna. J Comp Pathol 1981; 91: 185-91.
407. McGuire TC, Adams DS, Johnson GC, et al. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res 1986; 47: 537-40.
408. Knowles D, Jr., Cheevers W, McGuire T, Stem T, Gorham J. Severity of arthritis is predicted by antibody response to gp135 in chronic infection with caprine arthritis-encephalitis virus. J Virol 1990; 64: 2396-8.
409. McGuire TC, Knowles DP, Jr., Davis WC, et al. Transmembrane protein oligomers of caprine arthritis-encephalitis lentivirus are immunodominant in goats with progressive arthritis. J Virol 1992; 66: 3247-50.
410. Bertoni G, Zahno ML, Zanoni R, et al. Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis. J Virol 1994; 68: 7139-47.
411. Kajikawa O, Lairmore MD, DeMartini JC. Analysis of antibody responses to phenotypically distinct lentiviruses. J Clin Microbiol 1990; 28: 764-70.
412. Babas T, Vieler E, Hauer DA, et al. Pathogenesis of SIV pneumonia: selective replication of viral genotypes in the lung. Virology 2001; 287: 371-81.
413. McCrossan M, Marsden M, Carnie FW, et al. An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 2006; 129: 503-16.
414. Andiman WA, Eastman R, Martin K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985; 2: 1390-3.
415. Barbera JA, Hayashi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992; 145: 940-6.
416. Kaan PM, Hegele RG, Hayashi S, Hogg JC. Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia. Thorax 1997; 52: 12-6.
417. Reddy A, Lyall EG, Crawford DH. Epstein-Barr virus and lymphoid interstitial pneumonitis: an association revisited. Pediatr Infect Dis J 1998; 17: 82-3.
418. Teirstein AS, Rosen MJ. Lymphocytic interstitial pneumonia. Clin Chest Med 1988; 9: 467-71.
419. Resnick L, Pitchenik AE, Fisher E, Croney R. Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex. Am J Med 1987; 82: 553-6.
420. Ziza JM, Brun-Vezinet F, Venet A, et al. Lymphadenopathy- associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. N Engl J Med 1985; 313: 183.
421. Chayt KJ, Harper ME, Marselle LM, et al. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA 1986; 256: 2356-9.
422. Linnemann CC, Jr., Baughman RP, Frame PT, Floyd R. Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS. Chest 1989; 96: 64-7.
423. Scarborough M, Lishman S, Shaw P, Fakoya A, Miller RF. Lymphocytic interstitial pneumonitis in an HIV-infected adult: response to antiretroviral therapy. Int J STD AIDS 2000; 11: 119-22.
424. Hanna Z, Kay DG, Cool M, et al. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J Virol 1998; 72: 121-32.
425. Hayman M, Arbuthnott G, Harkiss G, et al. Neurotoxicity of peptide analogues of the transactivating protein tat from Maedi-Visna virus and human immunodeficiency virus. Neuroscience 1993; 53: 1-6.
426. Cashion MF, Banks WA, Bost KL, Kastin AJ. Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res 1999; 822: 26-33.
427. Lambotte O, Deiva K, Tardieu M. HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era. Brain Pathol 2003; 13: 95-103.
428. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214: 231-41.